[1] |
Chen H, Li N, Ren J, et al. Participation and yield of a population-based colorectal cancer screening programme in China [J]. Gut, 2018, 2018-317124.
|
[2] |
Segelman J, Granath F, Holm T, et al. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer [J]. British Journal of Surgery, 2012, 99(5): 699-705.
|
[3] |
Augestad KM, Bakaki PM, Rose J, et al. Metastatic spread pattern after curative colorectal cancer surgery. A retrospective, longitudinal analysis [J]. Cancer Epidemiology, 2015, 39(5): 734-744.
|
[4] |
van Gestel YRBM, Thomassen I, Lemmens VEPP, et al. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer [J]. European Journal of Surgical Oncology (EJSO), 2014, 40(8): 963-969.
|
[5] |
Koppe MJ, Boerman OC, Oyen WJG, et al. Peritoneal Carcinomatosis of Colorectal Origin [J]. Annals of Surgery, 2006, 243(2): 212-222.
|
[6] |
Pamela K, Matthias Z, Reinhold KR, et al. Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria [J]. Journal of Gastrointestinal Surgery, 2018, 22(3): 1-10.
|
[7] |
Ying H. The progression of exploratory development of raltitrexed in colorectal cancer [J]. Journal of Modern Oncology, 2012, 27(3): 276-285.
|
[8] |
Bendavid Y, Leblond F. A study of the effect of temperature on the pharmacokinetic profile of raltitrexed administered by intraperitoneal route in the rat [J]. Medical Science Monitor International Medical Journal of Experimental & Clinical Research, 2005, 11(1): 1-5.
|
[9] |
Nguyen D, Emond C, Leclerc Y, et al. Pharmacokinetics studies and toxicity profile of raltitrexed used by intraperitoneal route in normothermia in a pig model [J]. Medical Science Monitor International Medical Journal of Experimental & Clinical Research, 2003, 9(1): R37-R42.
|
[10] |
Segelman J, Granath F, Holm T, et al. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer [J]. Br J Surg, 2012, 99(5): 699-705.
|
[11] |
Verwaal VJ, Bruin S, Boot H, et al. 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer [J]. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology, 2003, 21(20): 3737-3743.
|
[12] |
Gestel YRBM, Thomassen I, Lemmens VEPP, et al. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer [J]. European Journal of Surgical Oncology the Journal of the European Society of Surgical Oncology & the British Association of Surgical Oncology, 2014, 40(8): 963-969.
|
[13] |
Solomon MJ, Egan M, Roberts RA, et al. Incidence of free colorectal cancer cells on the peritoneal surface [J]. Diseases of the Colon & Rectum, 1997, 40(11): 1294.
|
[14] |
Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-ynecologic malignancies [J]. Cancer, 2000, 88(2): 358-363.
|
[15] |
Hompes D, Tiek J, Wolthuis A, et al. HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome? [J]. Annals of Oncology Official Journal of the European Society for Medical Oncology, 2012, 23(12): 3123.
|
[16] |
Sugarbaker PH. Colorectal Cancer: Prevention and Management of Metastatic Disease [J]. Biomed Res Int, 2014, 2014(2): 782890.
|
[17] |
Pohlen U, Rieger H, Kunick-Pohlen S, et al. Phase II study of regional chemotherapy using the hypoxic abdominal perfusion technique in advanced abdominal carcinoma. 5-FU pharmacokinetics, complications and outcome [J]. Anticancer Research, 2007, 27(1B): 667-674.
|
[18] |
Reema H, Vanessa S, Olga U, et al. Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy [J]. Anz Journal of Surgery, 2010, 76(3): 156-161.
|
[19] |
王雪玮, 周海涛, 王锡山. 结直肠癌术中腹腔化疗专家意见(2017版) [J/CD]. 中华结直肠疾病电子杂志, 2017, 6(6): 442-446.
|
[20] |
苏昊, 周海涛, 王锡山, 等. 洛铂用于结直肠癌术中腹腔灌洗化疗的近期疗效分析[J/CD]. 中华结直肠疾病电子杂志, 2018, 7(2): 125-129.
|
[21] |
Ping Z, Zhi D, Tang L, et al. Preliminary investigation of intraperitoneal raltitrexed in patients with gastric cancer [J]. World Journal of Surgical Oncology, 2014, 12(1): 1-7.
|